Jan Hodek

1.6k total citations
45 papers, 872 citations indexed

About

Jan Hodek is a scholar working on Molecular Biology, Epidemiology and Organic Chemistry. According to data from OpenAlex, Jan Hodek has authored 45 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Epidemiology and 10 papers in Organic Chemistry. Recurrent topics in Jan Hodek's work include Genetically Modified Organisms Research (5 papers), Hepatitis B Virus Studies (5 papers) and RNA and protein synthesis mechanisms (5 papers). Jan Hodek is often cited by papers focused on Genetically Modified Organisms Research (5 papers), Hepatitis B Virus Studies (5 papers) and RNA and protein synthesis mechanisms (5 papers). Jan Hodek collaborates with scholars based in Czechia, United States and Germany. Jan Hodek's co-authors include Jan Weber, Jaroslava Ovesná, Přemysl Landa, Helena Štorchová, Tomáš Vaněk, Radomı́ra Vaňková, Petr Maršík, Jason C. White, Zuzana Mikulková and Petra Faltejsková and has published in prestigious journals such as PLoS ONE, Journal of Hazardous Materials and Scientific Reports.

In The Last Decade

Jan Hodek

40 papers receiving 863 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Hodek Czechia 15 297 166 142 121 110 45 872
Qingxia Wang China 19 296 1.0× 299 1.8× 119 0.8× 86 0.7× 70 0.6× 67 1.1k
Shahanavaj Khan Saudi Arabia 22 684 2.3× 276 1.7× 108 0.8× 105 0.9× 92 0.8× 55 1.5k
Jin Hu China 22 489 1.6× 112 0.7× 78 0.5× 206 1.7× 146 1.3× 42 1.4k
Aijun Sun China 19 337 1.1× 98 0.6× 59 0.4× 352 2.9× 220 2.0× 69 1.4k
Xiaoli Xia China 17 213 0.7× 63 0.4× 154 1.1× 60 0.5× 66 0.6× 66 875
Sunil More United States 14 222 0.7× 60 0.4× 87 0.6× 77 0.6× 70 0.6× 56 685
Anuradha Balasubramanian United States 17 365 1.2× 77 0.5× 141 1.0× 212 1.8× 80 0.7× 26 1.0k
Muzammal Hussain China 17 527 1.8× 94 0.6× 86 0.6× 91 0.8× 87 0.8× 38 1.1k
Sagnik Nag India 18 379 1.3× 158 1.0× 177 1.2× 53 0.4× 30 0.3× 45 1.1k
Yidan Zhou China 16 277 0.9× 132 0.8× 54 0.4× 108 0.9× 84 0.8× 50 709

Countries citing papers authored by Jan Hodek

Since Specialization
Citations

This map shows the geographic impact of Jan Hodek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Hodek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Hodek more than expected).

Fields of papers citing papers by Jan Hodek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Hodek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Hodek. The network helps show where Jan Hodek may publish in the future.

Co-authorship network of co-authors of Jan Hodek

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Hodek. A scholar is included among the top collaborators of Jan Hodek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Hodek. Jan Hodek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bereczki, Ilona, et al.. (2025). Synthesis of 3′-modified xylofuranosyl nucleosides bearing 5′-silyl or -butyryl groups and their antiviral effect against RNA viruses. European Journal of Pharmaceutical Sciences. 209. 107107–107107.
2.
Priksz, Dániel, Ilona Bereczki, Jan Hodek, et al.. (2025). Synthesis, H2S releasing properties, antiviral and antioxidant activities and acute cardiac effects of nucleoside 5′-dithioacetates. Scientific Reports. 15(1). 2876–2876.
4.
Herrmann, Lars, Ivan A. Yaremenko, Aysun Çapcı, et al.. (2022). Synthesis and in vitro Study of Artemisinin/Synthetic Peroxide‐Based Hybrid Compounds against SARS‐CoV‐2 and Cancer. ChemMedChem. 17(9). e202200005–e202200005. 29 indexed citations
5.
Vaňková, Eva, Jan Hodek, Josef Khun, et al.. (2022). Decontamination of High-Efficiency Mask Filters From Respiratory Pathogens Including SARS-CoV-2 by Non-thermal Plasma. Frontiers in Bioengineering and Biotechnology. 10. 815393–815393. 7 indexed citations
6.
Machara, Aleš, Pavel Majer, Jan Hodek, et al.. (2022). Thermodynamic and structural characterization of an optimized peptide-based inhibitor of the influenza polymerase PA-PB1 subunit interaction. Antiviral Research. 208. 105449–105449. 5 indexed citations
7.
Hodek, Jan, Karel Chalupský, Martin Dračínský, et al.. (2021). Discovery of Modified Amidate (ProTide) Prodrugs of Tenofovir with Enhanced Antiviral Properties. Journal of Medicinal Chemistry. 64(22). 16425–16449. 13 indexed citations
8.
Hodek, Jan, Karel Chalupský, Petra Krafčíková, et al.. (2021). Localization of SARS-CoV-2 Capping Enzymes Revealed by an Antibody against the nsp10 Subunit. Viruses. 13(8). 1487–1487. 11 indexed citations
9.
Janovec, V., Jan Hodek, Jiří Froněk, et al.. (2020). Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytes. Scientific Reports. 10(1). 12767–12767. 18 indexed citations
10.
Pachl, Petr, Jan Hodek, Aleš Machara, et al.. (2020). structural characterization of the interaction between the C-terminal domain of the influenza polymerase PA subunit and an optimized small peptide inhibitor. Antiviral Research. 185. 104971–104971. 5 indexed citations
11.
Vaňková, Eva, Josef Khun, Jaroslav Julák, et al.. (2020). Polylactic acid as a suitable material for 3D printing of protective masks in times of COVID-19 pandemic. PeerJ. 8. e10259–e10259. 35 indexed citations
12.
Hodek, Jan, et al.. (2019). Novel influenza inhibitors designed to target PB1 interactions with host importin RanBP5. Antiviral Research. 164. 81–90. 8 indexed citations
13.
Perlíková, Pavla, Chao Yang, Radek Pohl, et al.. (2018). Isomeric Naphtho‐Fused 7‐Deazapurine Nucleosides and Nucleotides: Synthesis, Biological Activity, Photophysical Properties and Enzymatic Incorporation to Nucleic Acids. European Journal of Organic Chemistry. 2018(37). 5092–5108. 10 indexed citations
14.
Weber, Jan, Richard M. Gibson, Jan Hodek, et al.. (2017). Impaired human immunodeficiency virus type 1 replicative fitness in atypical viremic non-progressor individuals. AIDS Research and Therapy. 14(1). 15–15. 11 indexed citations
15.
Lubyová, Barbora, et al.. (2017). PRMT5: A novel regulator of Hepatitis B virus replication and an arginine methylase of HBV core. PLoS ONE. 12(10). e0186982–e0186982. 42 indexed citations
17.
Nauš, Petr, Pavla Perlíková, Lenka Poštová Slavětínská, et al.. (2015). Synthesis and biological profiling of 6- or 7-(het)aryl-7-deazapurine 4′-C-methylribonucleosides. Bioorganic & Medicinal Chemistry. 23(23). 7422–7438. 15 indexed citations
18.
Janská, Anna, Jan Hodek, Pavel Svoboda, et al.. (2013). The choice of reference gene set for assessing gene expression in barley (Hordeum vulgare L.) under low temperature and drought stress. Molecular Genetics and Genomics. 288(11). 639–649. 54 indexed citations
19.
Ovesná, Jaroslava & Jan Hodek. (2009). Detection of transgenic papaya lines: extraction protocol optimisation and verification of DNA quality by PCR assay.. Czech Journal of Food Sciences. 27. 75–81. 1 indexed citations
20.
Héžová, Renata, Ondřej Slabý, Petra Faltejsková, et al.. (2009). microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients. Cellular Immunology. 260(2). 70–74. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026